|
1
|
Raff M: Cell suicide for beginners.
Nature. 396:119–122. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jacobson MD, Weil M and Raff MC:
Programmed cell death in animal development. Cell. 88:347–354.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Theodoropoulos GE, Gazouli M, Vaiopoulou
A, Leandrou M, Nikouli S, Vassou E, Kouraklis G and Nikiteas N:
Polymorphisms of caspase 8 and caspase 9 gene and colorectal cancer
susceptibility and prognosis. Int J Colorectal Dis. 26:1113–1118.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hajra KM and Liu JR: Apoptosome
dysfunction in human cancer. Apoptosis. 9:691–704. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nicholson DW and Thornberry NA: Caspases:
killer proteases. Trends Biochem Sci. 22:299–306. 1997. View Article : Google Scholar
|
|
6
|
Kesarwani P, Mandal RK, Maheshwari R and
Mittal RD: Influence of caspases 8 and 9 gene promoter polymorphism
on prostate cancer susceptibility and early development of hormone
refractory prostate cancer. BJU Int. 107:471–476. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Son JW, Kang HK, Chae MH, Choi JE, Park
JM, Lee WK, Kim CH, Kim DS, Kam S, Kang YM and Park JY:
Polymorphisms in the caspase-8 gene and the risk of lung cancer.
Cancer Genet Cytogenet. 169:121–127. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lan Q, Zheng T, Chanock S, Zhang Y, Shen
M, Wang SS, Berndt SI, Zahm SH, Holford TR, Leaderer B, et al:
Genetic variants in caspase genes and susceptibility to non-Hodgkin
lymphoma. Carcinogenesis. 28:823–827. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hosgood HD III, Baris D, Zhang Y, Zhu Y,
Zheng T, Yeager M, Welch R, Zahm S, Chanock S, Rothman N and Lan Q:
Caspase polymorphisms and genetic susceptibility to multiple
myeloma. Hematol Oncol. 26:148–151. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
von Elm E, Altman DG, Egger M, Pocock SJ,
Gøtzsche PC and Vandenbroucke JP: STROBE Initiative: The
Strengthening the Reporting of Observational Studies in
Epidemiology (STROBE) statement: guidelines for reporting
observational studies. Epidemiology. 18:800–804. 2007.
|
|
11
|
Zhang L, Liu JL, Zhang YJ and Wang H:
Association between HLA-B*27 polymorphisms and
ankylosing spondylitis in Han populations: a meta-analysis. Clin
Exp Rheumatol. 29:285–292. 2011.PubMed/NCBI
|
|
12
|
Higgins JP and Thompson SG: Quantifying
heterogeneity in a meta-analysis. Stat Med. 21:1539–1558. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zintzaras E and Ioannidis JP:
Heterogeneity testing in meta-analysis of genome searches. Genet
Epidemiol. 28:123–137. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Peters JL, Sutton AJ, Jones DR, Abrams KR
and Rushton L: Comparison of two methods to detect publication bias
in meta-analysis. JAMA. 295:676–680. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fang CQ, Liu SL, Lou Y and Li JH:
Expression of the caspase 9 gene and its polymorphism distribution
in gastric cancer. Shijie Huaren Xiaohua Zazhi. 15:3190–3193.
2007.(In Chinese).
|
|
16
|
Lou Y, Fang CQ and Li JH: A study on the
expression of CASP9 gene and its polymorphism distribution in
non-small cell lung cancer. Zhonghua Yi Xue Yi Chuan Xue Za Zhi.
24:59–62. 2007.(In Chinese).
|
|
17
|
He XM, Wang LL, Fang CQ, Liu SL, Lou Y and
Li JH: Expression of CASP9 gene and its polymorphism distribution
in colon cancer. Shijie Huaren Xiaohua Zazhi. 16:2371–2375.
2008.(In Chinese).
|
|
18
|
Ulybina YM, Kuligina ESh, Mitiushkina NV,
Rozanov ME, Ivantsov AO, Ponomariova DN, Togo AV, Levchenko EV,
Shutkin VA, Brenister SI, et al: Coding polymorphisms in Casp5,
Casp8 and DR4 genes may play a role in predisposition to lung
cancer. Cancer Lett. 278:183–191. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu H: Correlation between DNA pepair gene
XRCC1 single nucleotide polymorphism and susceptibility to
hepatocellular carcinoma in Fusui County of Guangxi. Guangxi
Medical University; 2009
|
|
20
|
Alison MR and Sarraf CE: Apoptosis: a
gene-directed programme of cell death. JR Coll Physicians Lond.
26:25–35. 1992.PubMed/NCBI
|
|
21
|
Doonan F and Cotter TG: Morphological
assessment of apoptosis. Methods. 44:200–204. 2008. View Article : Google Scholar
|
|
22
|
Kumar S: Measurement of caspase activity
in cells undergoing apoptosis. Methods Mol Biol. 282:19–30.
2004.PubMed/NCBI
|
|
23
|
Kumar S and Dorstyn L: Analyzing caspase
activation and caspase activity in apoptotic cells. Methods Mol
Biol. 559:3–17. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nicholson DW: ICE/CED3-like proteases as
therapeutic targets for the control of inappropriate apoptosis. Nat
Biotechnol. 14:297–301. 1996. View Article : Google Scholar : PubMed/NCBI
|
